ClinicalTrials.Veeva

Menu

The Potential Role of Testosterone on Target Organ Damage in Postmenopausal Hypertensive Women

L

Lanzhou University

Status

Unknown

Conditions

Hypertension

Study type

Observational

Funder types

Other

Identifiers

NCT03451747
LanZhou

Details and patient eligibility

About

The incidence of CVD-related deaths is generally higher in women than men. Postmenopausal changes in estrogen/androgen ratio that induce a relative androgen excess have been proposed as important factors in the higher prevalence of hypertension. Therefore, the investigators hypothesize that testosterone has potential role between hypertension and target organ damage in postmenopausal hypertensive women. And the objective is to evaluate the effects of testosterone between hypertension and target organ damage in postmenopausal hypertensive women.

Enrollment

322 estimated patients

Sex

All

Ages

45 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of hypertension
  • Women are all postmenopausal
  • Men are matched with women.

Exclusion criteria

  • Secondary hypertension
  • Coronary disease
  • Heart failure
  • Arterial fibrillation
  • Previous myocardial infarction
  • Previous stroke
  • Malignant disease
  • Kidney failure
  • Liver failure
  • Neoplastic disease
  • Severe neurological diseases
  • Severe metabolic or organic decompensation
  • Refuse to sign the informed consent form

Trial design

322 participants in 2 patient groups

postmenopausal hypertensive women
mached hypertensive men

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems